epilepsy
The latest news about epilepsy: headlines, AI summaries and the full story from every source.
- Biohaven Licenses Epilepsy Candidate Opakalim for $795 Million
- Biohaven Completes Enrollment in RISE3 Trial for Opakalim
- Praxis Precision Medicines Shares Phase 2/3 POWER1 Study Findings
- LivaNova Reports Q1 2025 Earnings with Strong Organic Revenue Growth
- LivaNova Reports Q3 2025 Earnings with Strong Revenue Growth